Accessibility of trial reports for drugs stalling in development: a systematic assessment of registered trials

Design A systematic assessment of the availability of published research reports for publicly registered trials testing drugs stalling in clinical development (“stalled drugs”) and drugs receiving regulatory licensure in the same time period (“licensed drugs”).